Status:
RECRUITING
Sex Differences in the Vascular Effects of E-cigarette Use
Lead Sponsor:
Anna Stanhewicz, PhD
Conditions:
E-cigarette Use
Eligibility:
All Genders
18-24 years
Phase:
EARLY_PHASE1
Brief Summary
The use of electronic nicotine delivery systems, or e-cigarettes - colloquially referred to as "vaping" - in the United States has increased exponentially since their introduction to the US market in ...
Eligibility Criteria
Inclusion
- 18-24 years old
- one of the following:
- have no history of e-cigarette use
- be a current e-cigarette user who has been using e-cigarettes for 6 months or longer
Exclusion
- history of cardiovascular, metabolic, and/or skin diseases
- body mass index \>30 kg/m2
- blood pressure ≥140 systolic and/or ≥ 90 diastolic
- current or history of tobacco cigarette use
- current antihypertensive or cholesterol-lowering medication
- current use of cannabis, marijuana, and/or other illegal substances
- current use of stimulant drugs
- currently pregnant or breastfeeding
- allergy to materials used during the experiment (e.g. latex),
- known allergy to study drugs
- healthy control subjects will also be excluded if they have ever used e-cigarettes in the past
Key Trial Info
Start Date :
December 2 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06159608
Start Date
December 2 2023
End Date
December 1 2026
Last Update
December 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Iowa
Iowa City, Iowa, United States, 52242